BAILEY HART: Open Payments
NPI 1912521907 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 14 payments from 9 companies in 2025. Trend: 2023 $37 · 2024 $585 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $79 |
| Galderma Laboratories, L.P. | 3 | $53 |
| Botanix SB Inc | 2 | $47 |
| UCB, Inc. | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Almirall LLC | 1 | $16 |
Products named: DUPIXENT, SOFDRA, NEMLUVIO, Bimzelx, LIBTAYO, AYVAKIT, Zoryve, Seysara.
Industry payments across FL — which companies pay providers there.
